|
2022
|
Invention
|
Composition for increasing expression of blood coagulation factor gene,
comprising core-shell str... |
|
2020
|
G/S
|
Pharmaceutical agents affecting metabolism; vitamin and mineral preparations for medical use; cru... |
|
|
G/S
|
Medicine cases, portable, filled; pharmaceutical agents
affecting metabolism; vitamin and minera... |
|
|
Invention
|
Composition for alleviating, treating, or preventing skin diseases, containing thymus vulgaris ex... |
|
|
Invention
|
Composition for ameliorating, treating, or preventing skin diseases comprising echinacea purpurea... |
|
|
Invention
|
Oral composition for reducing body weight or body fat, containing artemisia dracunculus and tarax... |
|
2019
|
Invention
|
Composition for increasing expression of blood coagulation factor gene, comprising core-shell str... |
|
|
Invention
|
Composition for increasing the expression of a growth factor gene, comprising coreshell structure... |
|
|
Invention
|
Composition for increasing expression of growth factor gene, comprising core-shell structured mic... |
|
2018
|
Invention
|
Factor viii mutant expression vector with enhanced protein expression.
The present disclosure re... |
|
|
Invention
|
Factor viii variant-expressing vector with increased protein expression capacity. The present inv... |
|
|
G/S
|
Pharmaceuticals; therapeutic drugs and agents; non-prescription medicines; cardiovascular pharmac... |
|
2015
|
Invention
|
Candida and use thereof. Candida, the therapeutic agent containing FK506 derivative. The pharmace... |
|
2011
|
Invention
|
Sustained-release pellets containing tacrolimus as an active ingredient. The present invention re... |
|
1995
|
Invention
|
Method for preparing 1-n-ethylsisomicin. 1-N-ethylsisomicin represented by the following structur... |
